<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04116060</url>
  </required_header>
  <id_info>
    <org_study_id>Nitrate E.D.</org_study_id>
    <nct_id>NCT04116060</nct_id>
  </id_info>
  <brief_title>Dietary Nitrate and Erectile Dysfunction</brief_title>
  <official_title>Impact of Dietary Nitrate on Erectile Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Essen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Essen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An expanding number of studies suggest a therapeutic role for nitrate and nitrite, most
      notably in treatment and prevention of cardiovascular disease including ischemia-reperfusion
      injury and hypertension. The nutritional aspects of these cardioprotective effects are
      particularly intriguing since nitrate is abundant in our everyday diet. Nitrate improves
      vascular functions in old adults and improves ischemia reperfusion injury in experimental
      models.

      Whether dietary nitrate improves erectile dysfunction is not known and will be investigated
      in the present study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel Assignment to intervention vs. control</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Double blinded and randomised</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>The changes of erectile function</measure>
    <time_frame>4 Weeks</time_frame>
    <description>Erectile dysfunction improvement as measured by IIEF5 score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in oral microbiome</measure>
    <time_frame>4 Weeks</time_frame>
    <description>Change in oral microbiome after dietary nitrate ingestion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in cardiac diastolic function,</measure>
    <time_frame>4 weeks</time_frame>
    <description>Change in cardiac diastolic function as determined by echocardiography</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Erectile Dysfunction</condition>
  <arm_group>
    <arm_group_label>Nitrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary nitrate dissolved in water (0,12 mmol sodium-nitrate/kgBW/day) Dietary Supplement: Dietary nitrate 200 ml tab water with 0,12 mmol/kgBW sodium-nitrate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dietary sodium-chloride dissolved in water (0,12 mmol sodium-chloride/kgBW/day) Dietary Supplement: Dietary sodium-chloride 200 ml tab water with 0,12 mmol/kgBW sodium-chloride</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Nitrate</intervention_name>
    <description>Oral dietary nitrate supplementation with (0,12 mmol/kgBW sodium-nitrate)</description>
    <arm_group_label>Nitrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Placebo Comparator: Dietary sodium-chloride dissolved in water (0,12 mmol sodium-chloride/kgBW/day)</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with erectile Dysfunction (IIEF5: 8-21) PDE-5 Inhibitors Responder Aged 41-74
        years

        Exclusion Criteria:

          -  Hypogonadism

          -  Spinal cord disease

          -  Insulin dependent Diabetes mellitus

          -  Prostate cancer after operation, radiotherapy and hormone therapy

          -  Treatment with NO-Donators or sGC-Activators

          -  Chronic kidney disease (Stage IV-V)

          -  Advanced liver dysfunction
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tienush Rassaf, Prof</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Essen</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christos Rammos, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Essen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christos Rammos, MD</last_name>
    <phone>020172384808</phone>
    <email>Christos.Rammos@uk-essen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Essen</name>
      <address>
        <city>Essen</city>
        <state>NRW</state>
        <zip>45122</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fadi Al-Rashid, Dr.med.</last_name>
      <phone>00492017230</phone>
      <email>fadi.al-rashid@uk-essen.de</email>
    </contact>
    <investigator>
      <last_name>Christos Rammos, MD, PHD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 3, 2019</study_first_submitted>
  <study_first_submitted_qc>October 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2019</study_first_posted>
  <last_update_submitted>October 3, 2019</last_update_submitted>
  <last_update_submitted_qc>October 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Essen</investigator_affiliation>
    <investigator_full_name>Fadi Al-Rashid</investigator_full_name>
    <investigator_title>MD, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Erectile Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

